This inventor holds 1 USPTO granted patent. Top assignee: Institut Fur Chemo-Und Biosensorik Munster E.v.. Active years: 2005.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2005
Title: Uta Schulze-Pellengahr: Innovator in Medical Detection Methods
Introduction
Uta Schulze-Pellengahr is a notable inventor based in Ascheberg, Germany. She has made significant contributions to the field of medical diagnostics, particularly in the detection of specific compounds in biological samples. Her innovative work has the potential to enhance patient care and diagnostic accuracy.
Latest Patents
Uta Schulze-Pellengahr holds a patent for a method titled "Method for detecting α-oxoaldehydes in the whole blood, blood plasma and/or serum of a patient." This method involves analyzing a respiratory air sample for the presence of at least one α-oxoaldehyde. The results of this analysis are then used to determine the presence of α-oxoaldehydes in the whole blood, blood plasma, and/or serum of the patient. This innovative approach could lead to more effective monitoring and diagnosis of various medical conditions.
Career Highlights
Uta is associated with the Institut für Chemo- und Biosensorik Münster e.V., where she continues to develop her research and innovations. Her work is characterized by a commitment to advancing medical technology and improving diagnostic methods.
Collaborations
Uta collaborates with Wolfgang Kleibohmer, who is also involved in research and development within the same institution. Their partnership exemplifies the collaborative spirit that drives innovation in the scientific community.
Conclusion
Uta Schulze-Pellengahr is a pioneering inventor whose work in medical detection methods is making a significant impact. Her patent for detecting α-oxoaldehydes showcases her dedication to improving healthcare diagnostics. Through her career and collaborations, she continues to contribute to advancements in medical technology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile